awmsg logo



emtricitabine/tenofovir (Truvada®)


Reference No. 123

Publication date:
10/08/2007


Appraisal information

emtricitabine/tenofovir (Truvada®) film-coated tablet


Company: Gilead Sciences Ltd
BNF category: Infections
NMG meeting date: 17/05/2007
AWMSG meeting date: 12/06/2007
   
   
Submission Type: Full Submission
Status: Recommended
Advice No: 0507
Ministerial ratification: 30/07/2007

Current Progress


Submission
received
NMG
meeting
AWMSG
meeting
Ministerial
Ratification

AWMSG advice

Emtricitabine/tenofovir DF (Truvada®) is recommended for use within NHS Wales as an option for the treatment of Human Immunodeficiency Virus (HIV-1) infected adults who are treatment-naïve and in line with current BHIVA guidelines. It should only be prescribed by HIV specialists.
Final Appraisal Recommendation (FAR)
Download